Source: DGNews | Posted 10 years ago
Positive Effects of Herceptin on Breast Cancer Outcomes Unrelated to Cardiac Dysfunction
Tags:
By Robert H. Carlson
SAN ANTONIO, TX -- December 13, 2001 -- The monoclonal antibody Herceptin (trastuzumab) can enhance the clinical benefit of chemotherapy in women with advanced breast cancer.
The benefits of Herceptin extend even to those women who develop cardiac dysfunction, according to researchers at the University of California at San Francisco (UCSF), in San Francisco, California, and Memorial Sloan-Kettering Cancer Center, in New York, New York.
Publication in 1998 of a pivotal trial on Herceptin, which led to the drug
Comments